IL-15RaFc Superagonist in NMIBC With Sam Chang, MD, MBA

By The Uromigos - Last Updated: August 1, 2023

Sam Chang, MD, MBA, joins The Uromigos to discuss his latest research in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC), as well as the clinical results of IL-15RαFc superagonist N-803 for papillary NMIBC.
Dr. Chang is Chief Surgical Officer at Vanderbilt Ingram Cancer Center, as well as Assistant Secretary of the American Urological Association.

Post Tags:Uromigos-Bladder Cancer